Select: News

May 05, 2008 VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc. Apr 08, 2008 VaxGen Restructures Following Termination of Proposed Merger Mar 28, 2008 VaxGen and Raven Terminate Merger Agreement Mar 24, 2008 VaxGen issues rebuttal to MedCap letter MedCap press releases contains false and misleading information Mar 20, 2008 VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger with Raven Only 7 Days Remain to Vote on the Proposed Merger Mar 13, 2008 VaxGen Common Stock Now Quoted on OTC Bulletin Board Quotation satisfies closing condition to the proposed merger with Raven biotechnologies, inc. Mar 06, 2008 VaxGen Reports Financial Update Feb 20, 2008 Momentum Continues for Merger of VaxGen and Raven Feb 08, 2008 - Investor/News Advisory - VaxGen to Present at the 10th Annual BIO CEO and Investor Conference Feb 08, 2008 VaxGen and Raven Announce Form S4 Registration Statement Declared Effective -- Companies Provide Update on Status of Integration Planning --  1   [2]  3   4   5   6   7  [ << ] [ < ] [ > ] [ >> ]